| Ayad K Agha, DO | |
|
3120 Willow Creek Rd Unit 100, Prescott, AZ 86301-6852 | |
| (480) 750-8130 | |
| (480) 590-2479 |
| Full Name | Ayad K Agha |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 27 Years |
| Location | 3120 Willow Creek Rd Unit 100, Prescott, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730113903 | NPI | - | NPPES |
| Entity Name | Banner -- University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508809427 PECOS PAC ID: 7719899871 Enrollment ID: O20031105000694 |
News Archive
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.
According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
› Verified 2 days ago
| Entity Name | Yuma Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194706655 PECOS PAC ID: 2062314826 Enrollment ID: O20040122000526 |
News Archive
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.
According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
› Verified 2 days ago
| Entity Name | Az-tech Radiology & Open Mri |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710199658 PECOS PAC ID: 1951356799 Enrollment ID: O20070518000525 |
News Archive
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.
According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
› Verified 2 days ago
| Entity Name | Progressive Pain Management Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881866754 PECOS PAC ID: 1153490727 Enrollment ID: O20080522000123 |
News Archive
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.
According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
› Verified 2 days ago
| Entity Name | Ctca Physicians Group Of Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609026806 PECOS PAC ID: 2264593474 Enrollment ID: O20081205000793 |
News Archive
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.
According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
› Verified 2 days ago
| Entity Name | Radadvantage A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376719666 PECOS PAC ID: 2163597899 Enrollment ID: O20091209000071 |
News Archive
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.
According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
› Verified 2 days ago
| Entity Name | Advanced Minimally Invasive Surgical |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295056919 PECOS PAC ID: 4183758527 Enrollment ID: O20100819001272 |
News Archive
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.
According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
› Verified 2 days ago
| Entity Name | Maria Gonzalez Berlari Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699025981 PECOS PAC ID: 2769625854 Enrollment ID: O20130820001092 |
News Archive
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.
According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
› Verified 2 days ago
| Entity Name | Hope Diabetes Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104865757 PECOS PAC ID: 4183620487 Enrollment ID: O20170719003937 |
News Archive
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.
According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
› Verified 2 days ago
| Entity Name | Mdig Of Arizona, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477056661 PECOS PAC ID: 5294080891 Enrollment ID: O20180622001741 |
News Archive
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.
According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
› Verified 2 days ago
| Entity Name | Dragha Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205491826 PECOS PAC ID: 1052390259 Enrollment ID: O20190723000247 |
News Archive
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.
According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
› Verified 2 days ago
| Entity Name | Summit Radiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073584587 PECOS PAC ID: 0143295410 Enrollment ID: O20200716002197 |
News Archive
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.
According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
› Verified 2 days ago
| Entity Name | Steward Radiology Physicians Of Arizona Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063052793 PECOS PAC ID: 9335563600 Enrollment ID: O20200729003684 |
News Archive
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.
According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
› Verified 2 days ago
| Entity Name | Allied Mobile Imaging, Llc |
|---|---|
| Entity Type | Part B Supplier - Portable X-ray Supplier |
| Entity Identifiers | NPI Number: 1154918811 PECOS PAC ID: 2567877442 Enrollment ID: O20210301000104 |
News Archive
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.
According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
› Verified 2 days ago
| Entity Name | X-ray Physicians Of Shelbyville Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144351347 PECOS PAC ID: 2264420215 Enrollment ID: O20211117001341 |
News Archive
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.
According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
› Verified 2 days ago
| Entity Name | Shps Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497490056 PECOS PAC ID: 7315325933 Enrollment ID: O20220615001044 |
News Archive
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.
According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ayad K Agha, DO 8787 N Scottsdale Rd Ste 105, Scottsdale, AZ 85253-2338 Ph: (480) 750-8130 | Ayad K Agha, DO 3120 Willow Creek Rd Unit 100, Prescott, AZ 86301-6852 Ph: (480) 750-8130 |
News Archive
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between the neurotransmitter dopamine and avoidance – behavior related to pain and fear.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.
According to a new report scientists funded by the chromium industry withheld key data from the U.S. government which called for a strict standard to be imposed regarding workplace exposure to hexavalent chromium.
Oregon Health & Science University Knight Cancer Institute researchers have found that an experimental drug successfully blocks an enzyme that causes some bone marrow cancers.
› Verified 2 days ago
Timothy D Olthoff, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 810 Whipple St, Prescott, AZ 86301 Phone: 928-771-7577 Fax: 928-458-2080 | |
Dr. Bernard Sakowicz, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 500 N Hwy 89, Northern Arizona Va Hcs, Prescott, AZ 86313 Phone: 928-445-4860 | |
Patrick K Hitchcock, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 500 N Us Highway 89, Prescott, AZ 86313 Phone: 928-776-6004 | |
Bruce Medford Burtan, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 2097 Summer Breeze Dr, Prescott, AZ 86303 Phone: 928-541-1714 | |
Dr. Mary M Poncel, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 500 N Hwy 89, Northern Arizona Va Hcs, Prescott, AZ 86313 Phone: 928-445-4860 | |
Dr. Mohamed A Kirdani, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 980 Willow Creek Rd, Prescott, AZ 86301 Phone: 928-443-0077 Fax: 928-443-0019 | |
Michael J D'angelo, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Ainsworth Dr, Suite 115, Prescott, AZ 86305 Phone: 928-778-1971 Fax: 928-443-8473 |